Actice Ingredient
(in each softgel)
Sennosides 17.2 mg
The following Structured Product Label (SPL) was submitted to the FDA by Softgel Healthcare Private Limited for the product Sennosides (NDC 35916-0423). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding actice ingredient, purpose, uses, do not use, ask a doctor before use if you have, stop use and consult a doctor if, if pregnant or breast-feeding,, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each softgel)
Sennosides 17.2 mg
Laxative
■ laxative products for longer than 1 week unless directed by a doctor
■ stomach pain
■ nausea
■ vomiting
■ noticed a sudden change in bowel habits that continues over a period of 2 weeks
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away
store below 30°C and protect from light and moisture
FD&C blue no.1, FD&C blue no.2, FD&C red no. 40, FD&C yellow no.6, fumaric acid, gelatin, glycerol, lecithin, liquid sorbitol, methyl hydroxy benzoate, purified water, refined soya oil, titanium dioxide, yellow bees wax.
call 1-877-770-3183: weekdays 9:00 AM to 4:30 PM EST
* Please review the disclaimer below.